This is the core reason a single published ratio cant be applied responsibly across all research use cases: the right volume depends on the protocol, not a fixed property of the peptide itself
Enter the concept of
[1] Together with toxic epidermal necrolysis (TEN) and StevensJohnson/toxic epidermal necrolysis (SJS/TEN) overlap, they are considered febrile mucocutaneous drug reactions and probably part of the same spectrum of disease, with SJS being less severe
Iron metabolism disorder, lipid peroxidation and decreased antioxidant capacity are involved in the occurrence of ferroptosis, and several key regulators (e.g., system Xc - , GPX4, p53 and ACSL4) play an important role in monitoring ferroptosis
SKBK, TM, FZ summarized the table and made the figures
The results of the phase III trial indicate common side effects in all groups [88]